SCHEMBL25218779

SCHEMBL25218779

COc1ccc(C(=O)C(CCN(C)C)Cc2ccccc2)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 6/20 0.56
BCHE P06276 5/20 0.56
LPAR1 Q92633 1/20 0.51
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
MAPT P10636 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
ALDH1A1 P00352 2/20 0.45
SLC6A4 P31645 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA4 P22748 1/20 0.44
CA6 P23280 1/20 0.44
CA7 P43166 1/20 0.44
TPMT P51580 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
HPGD P15428 1/20 0.44
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7124861 0.76 MAPK1 (0.50) ACHEBCHELPAR1NPC1RAB9A
SCHEMBL7124865 0.76 MAPK1 (0.50) ACHEBCHELPAR1NPC1RAB9A
SCHEMBL7321671 0.75 KMO (0.62) ACHEBCHENPC1RAB9AMAPT
SCHEMBL6249330 0.75 CCR1 (0.50) HPGD
Hydrochloric Acid SCHEMBL7164362 0.75 HTT (0.50) LPAR1NPC1RAB9AMAPTSMN1; SMN2
Hydrochloric Acid SCHEMBL7164363 0.75 HTT (0.50) LPAR1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL480432 0.74 ACHE (0.52) ACHEBCHENPC1RAB9AMAPT
SCHEMBL5564575 0.74 NPC1 (0.53) ACHEBCHELPAR1NPC1RAB9A
SCHEMBL17835816 0.73 SLC6A9 (0.52) ACHEBCHEALDH1A1SLC6A4
SCHEMBL17835817 0.73 SLC6A9 (0.52) ACHEBCHEALDH1A1SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12534618-B2 Curable silicone composition and cured product thereof DUPONT TORAY SPECIALTY MATERIALS KABUSHIKI KAISHA (JP) 2026-01-27 US disclosed
US-20230174722-A1 CURABLE SILICONE COMPOSITION AND CURED PRODUCT THEREOF DUROPTIX MATERIALS KABUSHIKI KAISHA (JP) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12534618-B2 Curable silicone composition and cured product thereof BHMT2, TST, BHMT ACHE 2967/4885BCHE 1769/4885LPAR1 4567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.